30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Miach Orthopaedics 2-Year Study Results on ACL Repair -

Results from a feasability study indicate that use of the Bridge-Enhanced® ACL Repair (BEAR®) procedure from Miach Orthopaedics resulted in similar clinical, functional and patient-reported outcomes as autograft ACL reconstruction at 24 months. BEAR is a bio-engineered sponge used as a bridging scaffold to stimulate healing of a torn ACL. Unlike traditional ACL reconstruction, the procedure does not require grafts from healthy parts of the leg. The BEAR I study also showed that BEAR recipients showed no infection or severe inflammatory response, arthrofibrosis or a reaction that required scaffold removal. Manual and instrumented measures suggest that the stability of the knee after both BEAR and autograft ACL reconstruction may be comparable. BEAR I was a non-randomized, two-arm study comparing 10 BEAR patients to 10 patients treated with autograft ACL reconstruction. Enrollment of 100 patients is complete for BEAR II, a randomized, blinded trial, and Miach is planning a third study to investigate the effects of patient age on outcomes. (Miach Orthopaedics, 3/12/19)